- Saffron (Crocus sativus) extract has been tested in dozens of small randomized trials, mostly for depressive symptoms.
- Meta-analyses report sizable benefits over placebo for mild-to-moderate depressive symptoms, but authors flag publication bias, small trials, and limited geographic diversity β many trials came from Iran.
- For memory, a 2020 systematic review found only four trials (203 patients): saffron performed similarly to donepezil or memantine in two small comparisons, but the evidence was too thin for clinical recommendations.
- Trials commonly used 30 mg/day of standardized saffron extract β a small amount, which makes standardization and authenticity important.
- Saffron is not a substitute for depression treatment. Talk to a clinician before using it with antidepressants, mood stabilizers, or during pregnancy.
What saffron extract is
Saffron is the dried stigma of the Crocus sativus flower β the world's most expensive spice by weight, because each flower yields only a few threads that are harvested by hand. Researchers attribute its effects to compounds such as crocin, crocetin, picrocrocin, and safranal.
The supplement form is usually a standardized extract taken in milligram amounts, not the threads you cook with. That distinction matters, because the trials used specific extracts and doses β and because a high-value, low-dose ingredient is exactly the kind that invites quality problems.
The mood evidence: bigger than you'd expect
Most saffron research is about depressive symptoms, and it has been pooled several times:
- A 2019 meta-analysis in Planta Medica pooled nine randomized trials for mild-to-moderate depression. Saffron was significantly more effective than placebo, and in comparisons with antidepressants the difference was not statistically significant β the authors described saffron as non-inferior, though the confidence interval was borderline.[1]
- A 2019 systematic review and meta-analysis in Nutrition Reviews included 23 studies and reported large effects versus placebo for both depressive and anxiety symptoms, and a large effect when saffron was added to antidepressants. The authors also found evidence of publication bias and limited regional diversity in the trials, and concluded more research is needed.[2]
"Large effect" headlines need context. When a field is dominated by small trials from a limited number of research groups and there are signs that negative trials went unpublished, pooled effect sizes tend to overstate reality. The fair reading: saffron has a consistent signal for mild-to-moderate depressive symptoms, and it deserves larger, independent, multi-country trials.
MODERATE: Saffron for mild-to-moderate depressive symptoms β many small RCTs, consistent signal, publication-bias concerns.If you're dealing with persistent low mood, loss of interest, or thoughts of self-harm, please contact a healthcare provider. In the U.S., you can call or text 988 for the Suicide & Crisis Lifeline. Saffron studies were in mild-to-moderate symptoms under research supervision.
The memory evidence: early and small
For cognition, the trial base is much thinner. A 2020 systematic review in BMC Complementary Medicine and Therapies found just four randomized trials with 203 patients β three in Alzheimer's disease from Iran and one in mild cognitive impairment from Greece.[3]
| Comparison | Population & dose | Result |
|---|---|---|
| Saffron vs placebo | Alzheimer's; 30 mg/day extract; 16 weeks | Better ADAS-cog and CDR-SB scores with saffron |
| Saffron vs donepezil | Alzheimer's; 30 mg/day extract; 22 weeks | Both improved; no significant difference between groups |
| Saffron vs memantine | Alzheimer's; 30 mg/day extract; about 12 months | Both improved; no significant difference between groups |
| Saffron vs no treatment | MCI; 125 mg/day saffron; 1 year | Trends favoring saffron; poor methodological quality |
The reviewers rated the Alzheimer's trials as moderate to high quality but concluded that the small number of trials makes the evidence insufficient for clinical recommendations, and called for larger placebo-controlled studies.[3] A "no difference from donepezil" result in a small trial is also not the same as proving equivalence β small trials often lack the power to detect real differences.
EARLY: Saffron for memory in Alzheimer's or MCI β four small trials; insufficient for recommendations.For healthy adults wanting a memory boost, there isn't a meaningful trial base yet. If memory is your main concern, compare the evidence in our ginkgo vs bacopa comparison and citicoline research review.
Doses seen in trials
Across the Alzheimer's trials, the dose was 30 mg per day of a standardized saffron extract.[3] Many mood trials used similar amounts. That's a tiny quantity β which means the extract's standardization (to markers such as crocins or safranal) and the product's authenticity matter more than they would for a gram-dose supplement.
More isn't better. Culinary amounts are a normal part of many cuisines, but safety data for amounts well above trial doses are limited, so don't exceed product directions or try to self-dose with large quantities of threads.
Adulteration and quality: buy carefully
Because saffron is so expensive, it has a long history of being adulterated or substituted with cheaper plant material and dyes. In a capsule you can't see the threads, so you're relying on the manufacturer's testing.
- Look for a named, standardized extract with the mg dose and standardization markers stated on the label.
- Prefer brands that publish batch testing (certificates of analysis) for identity and contaminants.
- Understand third-party seals: USP Verified or NSF Certified means an independent lab checked label contents and screened contaminants; it doesn't prove the product works. Confirm the seal on the specific product listing rather than assuming.
- Be wary of very cheap saffron supplements relative to the market and of "proprietary blends" that don't state the saffron dose.
Our explainer on blends vs single-ingredient supplements covers why hidden doses are a red flag.
Safety and interactions
In the cognition trials, adverse events were mild (nausea, dry mouth, fatigue, dizziness) and not significantly different from control groups.[3] Still, take these precautions:
- Antidepressants and mood stabilizers: some trials added saffron to antidepressants, but that was under research supervision. Don't combine without your prescriber's input.
- Bipolar disorder: anything with mood-elevating potential deserves caution; discuss with your psychiatrist.
- Pregnancy and breastfeeding: the safety of supplemental doses hasn't been established; avoid unless your obstetrician advises otherwise.
- Other medications: ask your pharmacist to screen for interactions before starting, especially if you take several prescriptions.
What to actually buy
If you and your clinician decide to try saffron, compare standardized extracts that state the mg dose (trials commonly used 30 mg/day). Check each listing for third-party testing and published batch results.
Saffron extract 30 mg (standardized)
Choose products that name the extract and its standardization, and state the dose per capsule.
Nutricost KSM-66 Ashwagandha
If stress is driving low mood or poor sleep, ashwagandha is the adaptogen we cover most β see our comparison for safety caveats.
Frequently asked questions
Does saffron help with depression?
Meta-analyses of small randomized trials report benefits over placebo for mild-to-moderate depressive symptoms, but authors note publication bias and limited diversity of trial locations. It isn't a substitute for professional care.
Does saffron improve memory?
Evidence is limited to four small trials in Alzheimer's disease and mild cognitive impairment. A 2020 review found the evidence insufficient for clinical recommendations.
How much saffron extract was used in studies?
The Alzheimer's trials used 30 mg per day of a standardized saffron extract.
Is saffron as good as donepezil?
One small 22-week trial found no significant difference between saffron and donepezil, but small trials can miss real differences. Saffron is not an established Alzheimer's treatment.
Is saffron safe to take with antidepressants?
Some research added saffron to antidepressants under supervision, but you should not combine them without talking to your prescriber.
Citations
- TΓ³th B, Hegyi P, Lantos T, et al. The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis. Planta Med. 2019;85(1):24β31. https://www.thieme-connect.com/products/ejournals/html/10.1055/a-0660-9565
- Marx W, Lane M, Rocks T, et al. Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis. Nutr Rev. 2019;77(8):557β571. https://pubmed.ncbi.nlm.nih.gov/31135916/
- Ayati Z, Yang G, Ayati MH, et al. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. BMC Complement Med Ther. 2020;20:333. https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-020-03102-3